Trials / Unknown
UnknownNCT02159456
Continuous Versus Intermittent Enteral Feeding in Critically Ill Patients
Continuous Versus Intermittent Enteral Feeding in Critically Ill Patients: a Prospective, Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
1. Nutritional support during critical illness is important to improve the clinical outcome of patients. Recently, the apply of early enteral nutrition is recommend in critically ill patients on basis of data that enteral nutrition can be helpful to prevent the hospital-acquired infections. * However, in critically ill patients, the smooth progress of nutritional support is often hindered by gastrointestinal intolerance, underlying clinical condition, and temporal necessity of procedure or operation. * Continuous feeding method, compared with intermittent feeding, is expected to reduce the risk of gastrointestinal intolerance, and improve the nutritional support, but this hypothesis is not supported by appropriate evidences. 2. We will elucidate to compare the efficacy and safety of the continuous feeding method in critically ill patients, compared with the intermittent feeding method. * Prospective, randomized controlled study * Primary outcome: the achievement rate of target nutritional goal within 7 days after the start of enteral nutrition * Secondary outcome: gastrointestinal tolerance, In-ICU/hospital mortality, frequency of hospital-acquired infection, ICU/hospital length-of-stay, duration of mechanical ventilation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Continuous enteral feeding via infusion pump | |
| OTHER | Intermittent enteral feeding via gravity-based infusion |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2014-06-10
- Last updated
- 2021-08-24
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02159456. Inclusion in this directory is not an endorsement.